Navigation Links
Full Sail University Welcomed Back to Campus Graduate and Acclaimed Horror Director, Darren Lynn Bousman
Date:11/20/2008

mpire Slayer, Paris Hilton in the role of Amanda Sweet, and Zdunich, in the role of Graverobber.

Bousman, who has embarked on a college tour to promote the film, returned to Full Sail University where he achieved his degree in Film in 2002. With a projector donated by SWANK Audio Visual, the event provided an exclusive screening to over 200 students and fulfilled Bousman's hope to share Repo! with future filmmakers who are eager to learn from his experience in the industry.

"Having the opportunity to return to Full Sail where I learned my craft and being able to share my work with the students and faculty was a truly rewarding experience," said Bousman. "It is my hope to inspire even one student to pursue their dreams just as I did, and place their unique footprint on the film industry."

Dave Franko, Program Director for Film further added, "Watching Darren's film and having the opportunity to hear him speak is not only an incredible lesson for our current students, but it is also a very proud moment for our faculty and staff. He is an inspiration to our students and a testament to our curriculum."

About Full Sail University:

Since 1979, Full Sail University, located outside of Orlando, FL, has been an innovative educational leader for those pursuing careers in the entertainment industry. With over 30,000 alumni, graduate credits include work on Oscar, Emmy and GRAMMY®-winning projects, best-selling video games, and the #1 grossing U.S. concert tours. Full Sail's 190-acre campus and online education platform proudly welcomes over 6,100 students from 50 states and 50 countries.

Full Sail currently o
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
2. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
3. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
4. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
5. The University of Nottingham in the British Midlands Announces Development of Possible Hepatitis C Vaccine
6. University of Leicester scientists discover technique to help friendly bacteria
7. MichBio Announces Student Career Day at Michigan State University
8. Dr. Thomas Van Dyke Renowned Boston University Professor Joins Imagenetixs Medical Advisory Board
9. University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement
10. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
11. McGill University Purchases GenVaults Personal Archive System to Manage Rare Cancer Samples
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Full Sail University Welcomed Back to Campus Graduate and Acclaimed Horror Director, Darren Lynn Bousman
Full Sail University Welcomed Back to Campus Graduate and Acclaimed Horror Director, Darren Lynn Bousman
(Date:2/8/2010)... the ClearTrial clinical services team to present the critical processes ... clinical development departments. , ... Chicago, ... of Clinical Trial Operations (CTO) software, today announced that both ... have been selected to speak at the CBI Forecasting & ...
(Date:2/6/2010)... University Belfast are developing new sensors to detect chemical ... fight against the threat of terrorist attacks. , The ... individual or crime scene to gather a sample which ... detect the presence of chemicals within seconds. This will ... to terrorist threats. , The scanning instrument will ...
(Date:2/5/2010)... Valencia (UV) has confirmed that the substance used to ... in Morocco, was pine resin. The scientists also studied ... be fragments of material used for iron-working. , In ... a sealed amphora among the remains at Lixus, an ... Morocco. Since then, researchers from the Department of Analytical ...
(Date:2/5/2010)... , Feb. 5 Amicus Therapeutics ... of Directors has elected John F. Crowley ... current role as Chief Executive Officer (CEO), effective immediately. ... , who will become the Lead Independent Director of ... Crowley as Chairman of the Board reflects our confidence ...
Breaking Biology Technology:ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 2ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 3ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 4New technology detects chemical weapons in seconds 2Chemical analyses uncover secrets of an ancient amphora 2Amicus Therapeutics Board of Directors Names Chief Executive Officer John F. Crowley Chairman of the Board 2
... Seventh Study Showing Oncotype DX Frequently Changes Treatment ... Recommendations in Clinical Practice -, ... GHDX ) today announced the publication of results from a ... treat early-stage breast cancer. The study, published in the,October issue ...
... Presented at the Meeting Report the Use of ... Tight Glycemic Control in,Diabetics, MONTVALE, N.J., Nov. ... today announced at the Annual Scientific,Sessions of the ... a,new clinical test to determine haptoglobin (Hp) genotype ...
... WaferGen Biosystems,Inc. (OTC Bulletin Board: WGBS), a leading developer ... research systems,today highlighted the company,s recent developments and announced ... 30, 2008., Recent Corporate Developments: -- ... awarded a team of researchers ...
Other Biology Technology:Genomic Health Announces Publication of a Study Demonstrating the Oncotype DX(R) Breast Cancer Assay Influences Chemotherapy Treatment Recommendation in 44 Percent of Patients Evaluated 2Genomic Health Announces Publication of a Study Demonstrating the Oncotype DX(R) Breast Cancer Assay Influences Chemotherapy Treatment Recommendation in 44 Percent of Patients Evaluated 3Genomic Health Announces Publication of a Study Demonstrating the Oncotype DX(R) Breast Cancer Assay Influences Chemotherapy Treatment Recommendation in 44 Percent of Patients Evaluated 4Synvista Therapeutics Announces Availability of Haptoglobin Genotyping Technology at The Annual Scientific Sessions of the American Heart Association 2Synvista Therapeutics Announces Availability of Haptoglobin Genotyping Technology at The Annual Scientific Sessions of the American Heart Association 3Synvista Therapeutics Announces Availability of Haptoglobin Genotyping Technology at The Annual Scientific Sessions of the American Heart Association 4Synvista Therapeutics Announces Availability of Haptoglobin Genotyping Technology at The Annual Scientific Sessions of the American Heart Association 5WaferGen Announces Third Quarter 2008 Financial Results 2WaferGen Announces Third Quarter 2008 Financial Results 3WaferGen Announces Third Quarter 2008 Financial Results 4WaferGen Announces Third Quarter 2008 Financial Results 5WaferGen Announces Third Quarter 2008 Financial Results 6WaferGen Announces Third Quarter 2008 Financial Results 7WaferGen Announces Third Quarter 2008 Financial Results 8WaferGen Announces Third Quarter 2008 Financial Results 9
(Date:2/8/2010)... offers a wealth of data about how cells respond ... systems is a daunting challenge. In a study ... ), researchers have developed a novel method of interpreting ... biological networks, offering a glimpse into the future of ... been peering through a microscope at cells as they ...
(Date:2/8/2010)... -- With the recent election of Senator Scott ... loss of the Democratic supermajority, the urgency behind broad-based ... for the majority of uninsured Americans has faded dramatically, ... recently noted the country is closer than it has ... a long sought after social reform, and the President ...
(Date:2/8/2010)... cancer is the most common cancer of the female ... is currently no screening method or biomarker to indicate ... malignancy that affects women of all ages" comments paper ... the cells that grow along the inner lining of ... it is diagnosed following patient reports of abnormal bleeding. ...
Breaking Biology News(10 mins):Method of the future uses single-cell imaging to identify gene interactions 2S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 2S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 3S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 4S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 5S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 6S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 7S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 8S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 9A potent suppressor of endometrial cancer is revealed 2Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 1Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 2Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 3Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 4Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 5Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 6Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 7Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 8Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 9Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 10Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 11Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 12Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 13Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 14Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 15Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 16Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 17JBFCS Surpasses Fundraising Goal For Hudson Valley Bike Ride Despite Difficult Financial Times 51594 1JBFCS Surpasses Fundraising Goal For Hudson Valley Bike Ride Despite Difficult Financial Times 51594 2Politicians to Drive on Straw Based Bioethanol at the Climate Change Conference 13014 1Politicians to Drive on Straw Based Bioethanol at the Climate Change Conference 13014 2Politicians to Drive on Straw Based Bioethanol at the Climate Change Conference 13014 3
... climate change, Cornell University entomologists show that the social behavior ... period of global warming. , This social evolution occurred ... million to 22 million years ago, compared with the social ... years ago. , "We believe that climatic change was a ...
... new bacterium in an immune-compromised patient, according to a ... belongs to the family Acetobacteraceae and includes bacteria common ... industry, such as vinegar-making. "This is the first ... of the Acetobacteraceae," according to the article. ...
... A new, more robust analysis of recently derived human ... University in St Louis, shows three distinct major waves ... two, and statistically refutes –strongly ?the 'Out of ... of Homo sapiens left Africa 100,000 years ago and ...
Other Biology News:Sociality of sweat bees evolved simultaneously during climate change 2Scientists discover a new disease-causing bacterium in an immune-compromised patient 2New analysis shows three human migrations out of Africa 2
The Bio-Plex Manager version 3.0 to 4.0 workstation software upgrade kit is used to upgrade existing Bio-Plex Manager version 3.0 software to version 4.0 security edition software....
... siRNA --- a cocktail of 3 siRNAs ... interestis our most popular product. The siTrio ... knockdown of your target gene when used ... transfection and confirmation of optimal transfection with ...
... offers a large collection of phage ... tissuea, cell lines, and mouse tissues. ... pHD9 vector. The size of cDNA ... from 200bp to 1000bp by gel ...
... This kit #27295 has improved stability and convenience ... kit not only has overcome this problem but ... we have changed the formulation of HRP conjugated ... 1). By this change, the stability of the ...
Biology Products: